News Detail
New Delhi, 15 June 2024: The National Pharmaceutical Pricing Authority (NPPA) has invoked the Para 3 of the Drugs (Prices Control) Order, 2013, and directed Mumbai-based Macleods Pharmaceuticals to supply anti-tuberculosis drug rifampicin 150 mg and 450 mg capsules to the c......
View Details
Source : Pharmabiz
NPPA
Para 3
Drugs (Prices Control) Order
Macleods Pharmaceuticals
anti-tuberculosis drug
rifampicin
Central Medical Services Society
CMSS
DPCO
2013
API
bulk drug
National Tuberculosis Elimination Programme
NTEP
Lok Sabha
Related News
- Rs 6.70 Lakhs Worth of Illegally Stored Medicines Confiscated from Godown in Uppal Khalsa (19-02-2025)
- Manufacturers asked to revise MRP for drugs with nil, reduced customs duty (19-02-2025)
- DCC recommends change in rules for regulatory oversight by CDSCO for approving antimicrobials (19-02-2025)
- Ayurvedic 'Ortho-Aid Oil' making misleading claim to treat 'Rheumatism' seized in Siricilla (18-02-2025)
- Three individuals arrested with 144 vials of Avil injections in Jaipur (18-02-2025)
- RG Kar Medical College ‘restricts use of Mannitol injection’ (18-02-2025)
- Hair oil mixed with rabbit blood: Drugs control and CDSCO officers inspected three locations in TN (18-02-2025)
- Maha FDA busts spurious drug racket; medicines worth ₹12.47 seized (18-02-2025)
- Bihar man booked in Haryana for online sale of abortion pills (18-02-2025)
- Glenmark, FDC recall products from US market on manufacturing issues: USFDA (17-02-2025)